This hottest twist from the Lykos Therapeutics saga threatens A serious overhaul of the corporation’s strategy and course, with Musk ally and billionaire investor Antonio Gracias showing to would like to just take the company back toward its nonprofit drug enhancement roots and a far more Doblinite philosophy.Patent programs are magic formula for